Noxopharm Ltd is an Australian clinical-stage drug development company focused on discovering and developing novel treatments for cancer and inflammation, as well as improving mRNA vaccines, based on two preclinical platforms... Show more
Industry Biotechnology
A.I.dvisor indicates that over the last year, NOXOF has been closely correlated with INSM. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if NOXOF jumps, then INSM could also see price increases.
| Ticker / NAME | Correlation To NOXOF | 1D Price Change % | ||
|---|---|---|---|---|
| NOXOF | 100% | N/A | ||
| INSM - NOXOF | 88% Closely correlated | +3.49% | ||
| NWPHF - NOXOF | 55% Loosely correlated | N/A | ||
| AGIO - NOXOF | 41% Loosely correlated | +1.92% | ||
| ONCO - NOXOF | 33% Loosely correlated | -0.17% | ||
| ARCT - NOXOF | 31% Poorly correlated | +2.23% | ||
More | ||||